Macrogenics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Macrogenics Inc.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.
/ 
Frequently asked questions
To buy Macrogenics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Macrogenics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Macrogenics Inc. is MGNX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Macrogenics Inc. has its primary listing on NASDAQ. You can trade Macrogenics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Macrogenics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Macrogenics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Macrogenics Inc..